Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma

被引：0

作者：

Kao, Hsiang-Fong ^{[1
]}

Huang, Huai-Cheng ^{[1
]}

Liao, Bin-Chi ^{[1
]}

Hong, Ruey-Long ^{[1
]}

机构：

[1] Natl Taiwan Univ Hosp, Taipei, Taiwan

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P273

引用

页数：1

共 50 条

[1] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
Kao, H-F.
Hong, R-L.
[J]. ANNALS OF ONCOLOGY, 2018, 29 : 379 - 379
[2] Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
Chen, Wen-Chun
Chu, Pen-Yuan
Lee, Yu-Ting
Lu, Wen-Bin
Liu, Chun-Yu
Chang, Peter Mu-Hsin
Yang, Muh-Hwa
[J]. MEDICINE, 2017, 96 (52)
[3] Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis
Kao, Hsiang-Fong
Liao, Bin-Chi
Huang, Yen-Lin
Huang, Huai-Cheng
Chen, Chun-Nan
Chen, Tseng-Cheng
Hong, Yuan-Jing
Chan, Ching-Yi
Chia, Jean-San
Hong, Ruey-Long
[J]. CLINICAL CANCER RESEARCH, 2022, 28 (08) : 1560 - 1571
[4] Pembrolizumab for cisplatin-failure recurrent/metastatic head and neck squamous cell carcinoma
Chen, W-C.
Chang, P. M-H.
Lee, Y-T.
Lu, W-B.
Yang, M-H.
[J]. ANNALS OF ONCOLOGY, 2016, 27
[5] Afatinib and pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (ALPHA Study): A phase II study with biomarker analysis.
Kao, Hsiang-fong
Liao, Bin-Chi
Huang, Yen-Lin
Huang, Huai-Cheng
Chen, Chun-Nan
Chen, Tseng-Cheng
Hong, Yuan-Jing
Chan, Ching-Yi
Hong, Ruey-Long
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[6] Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study
Okada, Takuro
Fushimi, Chihiro
Matsuki, Takashi
Tokashiki, Kunihiko
Takahashi, Hideaki
Okamoto, Isaku
Sato, Hiroki
Kondo, Takahito
Hanyu, Kenji
Kishida, Takuma
Ito, Tatsuya
Yamashita, Gai
Masubuchi, Tatsuo
Tada, Yuichiro
Miura, Koki
Omura, Go
Yamashita, Taku
Oridate, Nobuhiko
Tsukahara, Kiyoaki
[J]. ANTICANCER RESEARCH, 2023, 43 (06) : 2717 - 2724
[7] Role of Hematological Markers in Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab
Hagiwara, Kohei
Matsuki, Takashi
Okada, Takuro
Fushimi, Chihiro
Kondo, Takahito
Takahashi, Hideaki
Okamoto, Isaku
Tokashiki, Kunihiko
Hanyu, Kenji
Kishida, Takuma
Ito, Tatsuya
Yamashita, Gai
Tsukahara, Kiyoaki
Masubuchi, Tatsuo
Tada, Yuichiro
Momiyama, Kaho
Yaguchi, Ryohei
Oridate, Nobuhiko
Omura, Go
Yamashita, Taku
[J]. ANTICANCER RESEARCH, 2024, 44 (09) : 4057 - 4072
[8] Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
Saba, Nabil F.
Steuer, Conor E.
Ekpenyong, Asari
McCook-Veal, Ashley
Magliocca, Kelly
Patel, Mihir
Schmitt, Nicole C.
Stokes, William
Bates, James E.
Rudra, Soumon
Remick, Jill
McDonald, Mark
Abousaud, Marin
Tan, Aik Choon
Fadlullah, Muhammad Zaki Hidayatullah
Chaudhary, Ritu
Muzaffar, Jameel
Kirtane, Kedar
Liu, Yuan
Chen, Georgia Z.
Shin, Dong M.
Teng, Yong
Chung, Christine H.
[J]. NATURE MEDICINE, 2023, 29 (04) : 880 - 887
[9] Afatinib in squamous cell carcinoma of the head and neck
Specenier, Pol
Vermorken, Jan
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
[10] Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma
Iwaki, Sho
Kadowaki, Shigenori
Honda, Kazunori
Narita, Yukiya
Masuishi, Toshiki
Taniguchi, Hiroya
Ando, Masashi
Muro, Kei
Sawabe, Michi
Suzuki, Hidenori
Nishikawa, Daisuke
Beppu, Shintaro
Terada, Hoshino
Kishikawa, Toshihiro
Kawakita, Daisuke
Hanai, Nobuhiro
[J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (06) : 764 - 770

← 1 2 3 4 5 →